PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: General Electric Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GE Healthcare’s Next Generation Nuclear Cardiology Platform Goes Mainstream - Adopted by more than 100 leading clinicians worldwide, Alcyone technology has become an accepted technology for nuclear cardiology diagnosis (NYSE: GE) - GEHealthcare.com
GE Healthcare’s Next Generation Nuclear Cardiology Platform Goes Mainstream

 

NewswireToday - /newswire/ - Denver, CO, United States, 2011/09/08 - Adopted by more than 100 leading clinicians worldwide, Alcyone technology has become an accepted technology for nuclear cardiology diagnosis (NYSE: GE) - GEHealthcare.com. NYSE: GE

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Harnessing four advanced nuclear imaging innovations, Alcyone technology has the ability to reduce scan time and/or injected dose while maintaining image quality †

GE Healthcare today announced it has received commitments from more than 100 customers globally for its innovative Alcyone technology, a nuclear cardiology platform combining cadmium zinc telluride (CZT) detectors, focused pin-hole collimation, stationary data acquisition and 3D reconstruction, designed to help facilitate workflow efficiency and dose management while maintaining image quality.

“This revolution in GE Healthcare nuclear cardiology began in 2009 when we introduced our Alycone technology,” said Nathan Hermony, general manager of GE Healthcare’s Nuclear Imaging business. “Today, Alcyone technology has been adopted by clinicians around the world, a fact that we believe helps to validate its excellence in myocardial perfusion imaging and workflow. With our CZT-based technology strategy we are building a path to help clinicians maintain image quality while lowering dose and reducing exam time†, which could potentially have a positive impact on departments globally. GE Healthcare is continuously investing in CZT-based technology, as we believe CZT is helping revolutionize the industry and may potentially stimulate an era of growth in Nuclear Medicine.”

Alcyone technology is available on both the Discovery* NM 530c and the Discovery* NM/CT 570c. Alcyone’s significant improvement in sensitivity and zero equipment motion may enable the potential for new clinical applications for 3D dynamic acquisitions as well as the flexibility to manage patient dose more efficiently with up to four times lower injected dose. †

In February 2011, GE completed the acquisition of the assets of Orbotech Medical Solutions Ltd. (OMS), a subsidiary of Orbotech Ltd. (Orbotech), and a manufacturer of the CZT detectors used in the innovative Alcyone technology. Through the acquisition of OMS, GE Healthcare passed an important milestone in the growth of its Nuclear Medicine business.

Added Terri Bresenham, vice president and general manager of GE Healthcare’s Molecular Imaging business,“CZT based technology may help clinicians around the world provide patients with faster, and therefore potentially more comfortable, examinations at lower dose, and improve workflow while maintaining image quality†. We’ve entered a new frontier of possibilities in nuclear medicine as we employ CZT technology not only in cardiac exams, but apply it to other critical areas such the early detection of breast cancer.”

GE Healthcare’s Alcyone technology will be showcased with the Discovery NM 530c on display at the American Society of Nuclear Cardiology Annual Scientific Session in Denver, Colorado at booth 715.

† As compared to nuclear medicine gamma cameras using conventional detectors
*Trademarks of General Electric Company

About GE Healthcare
GE Healthcare (gehealthcare.com) provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

For our latest news, please visit newsroom.gehealthcare.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


GE Healthcare’s Next Generation Nuclear Cardiology Platform Goes Mainstream

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

GE News Center |
Publisher Contact: Rebecca Hayne - GE Healthcare 
414-721-3871 rebecca.hayne[.]ge.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From General Electric Company / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey
US Acute Care Solutions Celebrates 2-Year Anniversary
GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with Coronary CT Angiography
Telehealth Vendors Expand mHealth Portfolio to Conquer New Growth Opportunities Finds Frost & Sullivan
GE Healthcare Acquires Asymptote for Complete, Digitally-enabled Cryogenic Cold Chain Technology Supporting Safe Manufacture And Delivery Of Cellular
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil
GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare
Next-generation Natural Materials to Replace Traditional Synthetic Materials in Personal Care Products Finds Frost & Sullivan
Digital Innovation-driven Diagnostic Advances Transform Smart Healthcare Finds Frost & Sullivan
Hospitals’ Outsourcing of Sterile Processing Expand Opportunities for Third Party Service Providers in the US & Western Europe Finds Frost & Sullivan
Emerging Cardiac Therapies Catalysed by Innovative Product and Next-generation Technology Finds Frost & Sullivan
Austrian Centre of Industrial Biotechnology and GE Healthcare Establish A Cell Line Engineering Collaboration
Sequencing Platform Providers Aim to Develop Tests for Infectious Diseases to Expand Market Opportunity Finds Frost & Sullivan
Arcadia Wins Top Honors from Frost & Sullivan for its Next-generation Clinical and Claims Analytics Platform, Arcadia Analytics
Vendors Favour Platform Monitoring as Novel Service Models Disrupt APAC Home Health Monitoring Market Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Explorers Vacation Club

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)